Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shyam Srivats"'
Autor:
Dmitri Pchejetski, Caroline M. R. Low, Danielle Monteil, Heba Alshaker, Shyam Srivats, Qi Wang
Publikováno v:
Breast Cancer Research and Treatment
Purpose Sphingosine kinase 1 (SK1) is a protooncogenic enzyme expressed in many human tumours and is associated with chemoresistance and poor prognosis. It is a potent therapy target and its inhibition chemosensitises solid tumours. Despite recent ad
Publikováno v:
Breast Cancer Research and Treatment
Purpose Combining molecular therapies with chemotherapy may offer an improved clinical outcome for chemoresistant tumours. Sphingosine-1-phosphate (S1P) receptor antagonist and sphingosine kinase 1 (SK1) inhibitor FTY720 (FTY) has promising anticance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f47dc5fa3e04e07995c6faf227b3dcb
https://ueaeprints.uea.ac.uk/id/eprint/64323/
https://ueaeprints.uea.ac.uk/id/eprint/64323/
Autor:
Yimin Chao, Torsten Böhler, Colin Cooper, Heba Alshaker, Dmitri Pchejetski, Qi Wang, Shyam Srivats
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Many prostate cancers relapse after initial chemotherapy treatment. Combining molecular and chemotherapy together with encapsulation of drugs in nanocarriers provides effective drug delivery and toxicity reduction. We developed core shell lipid-polym